Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-02

Clinical Trial Update: Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC [Phase 2]

View source ↗

Summary

A Phase II trial evaluating the combination of simvastatin with irinotecan, fluorouracil, and leucovorin (FOLFIRI) for metastatic colorectal cancer has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLUOROURACIL (Fluorouracil)
  • Irinotecan (Irinotecan)
  • Leucovorin (folinic acid)
  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Samsung Medical Center | Conditions: Colorectal Cancer, Metastasis | Phase 2 | Status: COMPLETED